Option Care Health, Inc. is classed by the SEC under Services-Home Health Care Services (industry code 8082), based in Bannockburn, IL. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $5.6 billion and a profit of $208 million (its filed statements).
Usage businessServices-Home Health Care ServicesBannockburn, ILfilings since 19969 of 9 filed
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a usage business: prior from its industry code (SEC 8082, Services-Home Health Care Services); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 5.3 out of ten, 9 of 9 metrics filed: past 5.9 out of ten, present 5.9 out of ten, future 3.9 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
Surviving crises (past): 2.3 out of ten. 2 warning events since 2017; the latest 2019-08-13. 23rd percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Track record (past): 6.9 out of ten. +22.1% a year over 10 filed years; profitable in 6 of 10. 69th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Shareholder treatment (past): 9.1 out of ten. Share count shrank 3.6% a year. 85% of cash flow returned. Insiders: 2 sales, 5 purchases. 91st percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Financial health (present): 6.4 out of ten. ROE 16%: 16¢ of profit per shareholder dollar. Leverage 62%: owes 62¢ per asset dollar. 64th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Industry position (present): 6.1 out of ten. top 39% of 22 in its family; net margin 3.7%. 61st percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Leadership (present): 4.4 out of ten. bottom 44% of 19 in its family for leadership; chief executive since 2019. 44th percentile among 19 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
Room to expand (future): 4.0 out of ten. bottom 40% of 22 in its family for room to expand. 40th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Growth drivers (future): 4.1 out of ten. bottom 41% of 22 in its family for growth drivers. 41st percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Expectations vs reality (future): 3.6 out of ten. bottom 36% of 22 in its family for expectations against reality. 36th percentile among 22 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-24 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-07-29 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-07-29 (on EDGAR). Newest filing: Form DEFA14A, 2026-10-06. Filings on record since 1996. Read from EDGAR 2026-10-12.
Who runs it
Rademacher, John Charles (Chief Executive Officer); Sethna, Meenal (Chief Financial Officer); Whitworth, Luke (Chief Operating Officer); Adewunmi, Femi (Chief Medical Officer); Bavaro, Michael (Chief Human Resources Officer); Grashoff, Christopher L. (Chief Growth Officer); Maggio, Nicole (Chief Accounting Officer); Bhatia, Prateek (EVP Sp Sales & Solutions); Smyser, Collin (GC & Corporate Secretary); Bierbower, Elizabeth D (director); and 8 more. 18 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.